Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Clinical trial NCT00796614 · COMPLETED

Trial details

NCT number: NCT00796614
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bladder, Neurogenic

Start date: 2008-01-01
Primary completion: 2009-02-01
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.